Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy

International Journal of STD and AIDS

Volumn 22, Issue 9, 2011, Pages 498-504

  Adlakha, A ^a   Pavlou, M ^b   Walker, D A ^a   Copas, A J ^b   Dufty, N ^b   Batson, S ^a   Edwards, S G ^b   Singer, M ^a,b   Miller, R F ^b,c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

AIDS; HIV; Intensive care; Outcome; Pneumocystis pneumonia

Indexed keywords

ALBUMIN;

ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CONFIDENCE INTERVAL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APACHE; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; PNEUMONIA, PNEUMOCYSTIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 80052455146     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.010496     Document Type: Article

References (35)

1. Health Protection Agency. HIV in the United Kingdom: 2010 Report. Publication date 26 November 2010. See http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1287145367237 (last checked 29 January 2011)
2. Wachter RM, Luce JM, Turner J, et al. Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. Am Rev Respir Dis 1986; 134:891-6
3. Schein RM, Fischl MA, Pitchenik A, et al. ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med 1986; 14:1026-7
4. Smith RL, Levine SM, Lewis ML. Prognosis of patients with AIDS requiring intensive care. Chest 1989; 96:857-61
5. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-60
6. Valdez H, Chowdhry TK, Asaad R, et al. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995-1999. Clin Infect Dis 2001; 32:1487-93
7. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362:22-9
8. 3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr 2007; 46:72-7
9. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the Acute Respiratory Distress Syndrome. N Engl J Med 2000; 342:1301 8
10. Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Eng J Med 2006; 354:1671-84
11. Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C. Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Resp Crit Care Med 2002; 166:1510-04
12. Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomised controlled trial. JAMA 1999; 282:54-61
13. Morris A, Wachter RM, Luce J, et al. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003; 17:73-80
14. Narasimhan M, Posner AJ, DePalo VA, et al. Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest 2004; 125:1800-4
15. Vincent B, Timsit JF, Auburtin M, et al. Characteristics and outcomes of HIV-infected patients in the ICU. Impact of the highly active antiretroviral treatment era. Intensive Care Med 2004; 30:859-66
16. Casalino E, Wolff M, Ravaud P, et al. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004; 18:1429-33
17. Khouli H, Afrasiabi A, Shibli M, et al. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med 2005; 20:327-33
18. Palacios R, Hildalgo A, Reina C, et al. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit. HIV Med 2006; 7:193-6
19. Dickson SJ, Batson S, Copas AJ, et al. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax 2007; 62:964-8
20. Powell K, Davis JL, Morris AM, et al. Survival for patients with HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest 2009; 135:11-7
21. Coquet I, Pavie J, Palmer F, et al. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care 2010; 14:R107
22. Miller RF, Allen E, Copas A, et al. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax 2006; 61:716-21
23. Davis JL, Morris A, Kallet RH, et al. Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury. Thorax 2008; 63:988-93
24. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-67
25. Finfer S, Chittock DR, Yu-Shou Su S, et al., on behalf of the NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2006;360: 1283-97
26. Bernard GR, Vincent J-L, Laterre P-F, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
27. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N ENgl J Med 2001; 345: 1368-77
28. Reade MC, Huang DT, Bell D, et al., for the British Association for Emergency Medicine, the UK Intensive Care Society, the UK Society for Acute Medicine, the Australasian Resuscitation in Sepsis Evaluation (ARISE) Investigators and the Protocolized Care for Early Septic Shock (ProCESS) Investigators. Variability in management of early severe sepsis. Emerg Med J 2010; 27:110-5
29. Gill JK, Greene L, Miller R, et al. ICU admission in patients infected with the human immunodeficiency virus - a multicentre survey. Anaesthesia 1999; 54:727-32
30. Croda J, Croda MG, Neves A, De Sousa dos Santos S. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med 2009; 37:1605-11
31. Shaunak S, Veryard C, Javan C. Severe Pneumocystis carinii pneumonia increases the infectious titre of HIV-1 in blood and can promote the expansion of viral chemokine co-receptor tropism. J Infect 2001; 42:3-6
32. Harrison DA, Brady AR, Rowan K. Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the Intensive Care National Audit & Research Centre case mix programme database. Crit Care 2004; 8:R99-R111
33. British HIV Association (BHIVA). See http://www.bhiva.org/documents/ClinicalAudit/FindingsandReports/Mortality/Audit.ppt (last checked 20 October 2010)
34. British HIV Association. UK National Guidelines for HIV Testing 2008. See http://www.bhiva.org/HIVTesting2008.aspx (last checked 30 January 2011)
35. Zolopa A, Andersen J, Powderly W, et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 2009; 4:e5575